Background: Dengue hemorrhagic fever is an infectious ailment that exhibits a significantly elevated incidence rate in Indonesia. Dengue hemorrhagic fever can be classified into primary and secondary infection, where the secondary infection tends to cause more severe clinical manifestations. Hematocrit and platelet count are essential parameters observed in dengue hemorrhagic fever. This study aimed to analysed the existence of statistically significant differences in the level of hematocrit and platelet count between primary and secondary dengue hemorrhagic fever infections.
Methods: This study applied analytical observational cohort design with 60 samples in the form of medical record and laboratory data of hematocrit level and platelet count from patients diagnosed with dengue hemorrhagic fever.
Results: The results reveal significant differences in hematocrit and platelet values between primary and secondary DHF infection. Hematocrit value arises 2.73% higher (p = 0.043) and the platelet count drops 50,500/μl lower (p = 0.00) in secondary dengue hemorrhagic fever infection.
Conclusions: Significant differences of hematocrit and platelet values were found between primary and secondary dengue hemorrhagic infection. Clinicians should increase wary of secondary dengue hemorrhagic fever infected patients due to more severe clinical manifestations.
- World Health Organization. Dengue and Severe Dengue. [updated 2022 Jan 10; cited 2022 Jul 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
- Guerrant RL. Tropical Infectious Diseases Principle, Pathogens, and Practice. Elsevier. Amsterdam: Elsevier; 2004
- Gubler DJ. Dengue and Dengue Hemorrhagic Fever. Wallingford: CABI; 2014
- Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current Understanding of the Pathogenesis of Dengue Virus Infection. CurrMicrobiol 78, 17–32 (2021). https://doi.org/10.1007/s00284-020-02284-w
- World Health Organization. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever. [updated 2016 April; cited 2021 Jul 23]. Available from: https://apps.who.int/iris/handle/10665/204894
- DataIndonesia.id. Ada 73.518 Kasus Demam Berdarah Dengue di Indonesia pada 2021 [Cases of Dengue hemorrhagic Fever in Indonesia in 2021]. [updated 2022 August; cited 2022 Dec 7]. Available from: https://dataindonesia.id/ragam/detail/ada-73518-kasus-demam-berdarah-dengue-di-indonesia-pada-2021
- World Health Organization. Dengue Bulletin Volume 39, December 2016. [updated 2016 Dec; cited 2022 Jul 21]. Available from: https://apps.who.int/iris/handle/10665/255696
- Asih Y, Ester M. Demam Berdarah Dengue Diagnosis, Pengobatan, Pencegahan, dan Pengendalian Edisi 2 [Dengue Hemorrhagic Fever Diagnosis, Treatment, Prevention, and Control 2nd Edition] . Jakarta: Penerbit Buku Kedokteran ECG; 2012
- Soegijianto S. Demam Berdarah Dengue Edisi 2 [Dengue Hemorrhagic Fever 2nd Edition]. Surabaya: Pusat Penerbitan dan PercetakanUnair (AUP); 2006
- Akbar, M. I., Nurmaladewi, N., Aspian, P., Pagala, I., & Rustam, M. (2022). Assessing the service quality at health service facilities during the COVID-19 pandemic in North Buton District, Indonesia. Public Health of Indonesia, 8(4), 116-122.
- Sastroasmoro S. Dasar- Dasar Metodologi Penelitian Klinis Edisi ke-4 [Fundamentals of Clinical Research Methodology 4th Edition]. Jakarta: SagungSeto; 2011
- Frye JL, Thompson DF. (1993). Drug–induced thrombocytosis. Journal of Clinical Pharmacy and Therapeutics, 18(1), 45–48. https://doi.org/10.1111/j.1365-2710.1993.tb00565.x
- George JN, Aster RH. (2009). Drug-induced thrombocytopenia: Pathogenesis, evaluation, and Management.Hematology, 2009(1), 153–158. https://doi.org/10.1182/asheducation-2009.1.153
- Akbar, M. I., & Ali, L. (2020). Kajian Kebutuhan Tenaga Dokter Umum Dengan Menggunakan Metode Workload Indicator Staff Need (WISN) Di Poli Umum Dan Unit Gawat Darurat (UGD) Rsud Kabupaten Buton Utara. Miracle Journal of Public Health, 3(2), 153-162.
- Apriliani, A. Perbedaan Jumlah Trombosit, Leukosit dan Nilai Hematokrit pada Pasien DBD Berdasarkan Infeksi Primer dan Sekunder di RSD dr. A. Dadi Tjokrodipo Tahun 2020-2021 [Differences in Platelet Counts, Leukocytes, and Hematocrit Values in DHF Patients Based on Primary and Secondary Infections at RSD dr.A. Dadi Tjokrodipo 2020-2021] [tesis]. Lampung: Fakultas Teknologi Laboratorium Medis Politeknik Kesehatan Tanjungkarang.
- Siti Setiati, Alwi I, Sudoyo AW, Simadibrata MK, Setiyohadi B, Syam AF. Buku Ajar Ilmu Penyakit Dalam Jilid I Edisi VI [Textbook of Internal Medicine Volume I Edition VI]. Jakarta: InternaPublishing; 2014
- Stevens CD, Miller LE. Clinical Immunology and Serology A Laboratory Perspective 4th Edition (pp. 92-96). Philadelphia: F.A Davis Company; 2017
- KhurramM, QayyumW, HassanSJ, MumtazS, BushraHT, UmarM. (2014). Dengue hemorrhagic fever: Comparison of patients with primary and secondary infections. Journal of Infection and Public Health, 7(6), 489–495. https://doi.org/10.1016/j.jiph.2014.05.005
- Tirtadevi SN, Riyanti R, Wisudanti DD. Korelasi Jumlah Trombosit dan Kadar Hematokrit terhadap Tingkat Keparahan Pasien Demam Berdarah Dengue di RSD dr. Soebandi Jember [Correlation of Platelet Count and Hematocrit Levels to the Severity of Dengue Hemorrhagic Fever Patients at RSD dr. Soebandi Jember] . Journal of Agromedicine and Medical Sciences. 2021. 7(3): 156-161.
- Pusparini. Kadar hematokrit dan Trombosit Sebagai Indikator Diagnosis Infeksi Dengue Primer dan Sekunder [Hematocrit and Platelet Levels as Diagnostic Indicators for Primary and Secondary Dengue Infection] . Jurnal Kedokteran Trisakti. 2004. 24(2): 51-56.
Copyright (c) 2023 INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD)

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright Rights & Permissions Guide
Reproducing Published Material from other Publishers
It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).
Permission is required for:
- Your own works published by other Publishers and for which you did not retain copyright.
- Substantial extracts from anyones’ works or a series of works.
- Use of Tables, Graphs, Charts, Schemes and Artworks if they are unaltered or slightly modified.
- Photographs for which you do not hold copyright.
Permission is not required for:
- Reconstruction of your own table with data already published elsewhere. Please notice that in this case you must cite the source of the data in the form of either “Data from…” or “Adapted from…”.
- Reasonably short quotes are considered fair use and therefore do not require permission.
- Graphs, Charts, Schemes and Artworks that are completely redrawn by the authors and significantly changed beyond recognition do not require permission.
Obtaining Permission
In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. JNH cannot publish material from other publications without permission.
The copyright holder may give you instructions on the form of acknowledgement to be followed; otherwise follow the style: “Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].’ at the end of the caption of the Table, Figure or Scheme.
Every mansucript should be accompanied by "Copyright Transfer Agreement" prior to the article publication
Similar Articles
- Kabir Danjuma, Imrana Lawan, Saleh Jaafar , Shafiu Abdulmajid, PRELIMINARY QUALITATIVE PHYTOCHEMICAL SCREENINGS AND ANTIMICROBIAL POTENTIALS OF THE LEAF EXTRACTS OF MORINGA OLEIFERA GROWN IN ENUGU STATE, SOUTHEASTERN NIGERIA: THE LEAF EXTRACTS OF MORINGA OLEIFERA GROWN , INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD): Vol. 7 No. 1 (2025): INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT
- Auliya Ul-Humami, Dien Gusta Anggraini Nursal, Ratno Widoyo, THE RISK FACTORS FOR WASTING IN CHILDREN AGED 24–59 MONTHS IN RURAL AREAS OF WEST SUMATRA PROVINCE: ANALYSIS OF SKI 2023 DATA : WASTING IN CHILDREN AGED 24–59 MONTHS , INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD): Vol. 7 No. 2 (2025): INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT
- Usha Panta, Utilization Of Antibiotics In Patients With Urinary Tract Infections: Utilization Of Antibiotics , INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD): Vol. 4 No. 2 (2022): INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT
You may also start an advanced similarity search for this article.





